ProfileGDS2971 / 4.2.3.14
TitleHemiasterlin analog HTI-286 effect on docetaxel-resistant prostate cancer cell line
OrganismHomo sapiens


HTI-286 docetaxel GSM206100 GSM206166 GSM206167 GSM206168 GSM206169 GSM206170 GSM206357 GSM206358 GSM206359 GSM206360 GSM206361 GSM206362 61% 44% 79% 46% 84% 93% 57% 18% 72% 50% 56% 53% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM206100HTI-286 in docetaxel-refractory prostate cancer (Biological Replicate 1)0.2291261
GSM206166HTI-286 in docetaxel-refractory prostate cancer (Dye Flip 1)-0.016115244
GSM206167HTI-286 in docetaxel-refractory prostate cancer Biological Replicate 20.49437979
GSM206168HTI-286 in docetaxel-refractory prostate cancer (Biological Replicate 3)-0.042406846
GSM206169HTI-286 in docetaxel-refractory prostate cancer (Dye flip2)0.58114584
GSM206170HTI-286 in docetaxel-refractory prostate cancer (dyeflip3)1.1336693
GSM206357HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip1)0.1309557
GSM206358HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate1)-0.80574918
GSM206359HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip2)0.36253172
GSM206360HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate2)0.058969250
GSM206361HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip3)0.11526956
GSM206362HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate3)0.10840753